Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Response to L-ornitine L-aspartate in a single intravenous dose in cirrhotic patients with overt hepatic encephalopathy.
Yvonne Tadeo-Jiménez; Karla E. Pérez-Reséndiz; Aleida Bautista-Santos; Rosalba Moreno-Alcántar;
Ann Hepatol. 2025;30 Supl 1:
Adverse effects of the use of terlipressin infusion compared to boluses in patients with liver cirrhosis and variceal hemorrhage. TERMEX study.
Luis R. Antuna-Villaseñor; Germán A. Roman-Lugo; Jose Pérez-Sánchez; Alexis E. Chavarín-Meza; Yvonne Tadeo-Jiménez; Rosalba Moreno-Alcántar; Aleida Bautista-Santos;
Ann Hepatol. 2025;30 Supl 1:
Lymphopenia as a risk factor for mortality in patients with liver cirrhosis.
Carlos F. Fajardo¿Felix; Aleida Bautista-Santos; Hector H. Gonzalez-Anchondo; Daniela Lilian Andrade-Gonzalez; Rosalba Moreno-Alcántar;
Ann Hepatol. 2025;30 Supl 1: